Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
RESEARCH TOOLSreports
Arcutis Biotherapeutics (ARQT) Ownership - Who Owns Arcutis Biotherapeutics?
627 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 03, 2024 | Matthew Richard Moore Svp And Chief Business Officer | Sold | $40865 |
| Mar 06, 2024 | Patrick Heron Director | Bought | $199994 |
| Jan 03, 2024 | Patrick Burnett Reporting Person's Title: Svp And Chief Medical Officer | Sold | $4691 |
| Dec 01, 2023 | Todd Franklin Watanabe Reporting Person's Title: President And Ceo,director | Bought | $100002 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $201606 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,531,689 | Institution | 5.65% | 53,102,632 | |
| 4,878,752 | Institution | 4.22% | 39,664,254 | |
| 4,234,951 | Institution | 3.67% | 34,430,152 | |
| 4,054,419 | Institution | 3.51% | 32,962,426 | |
| 3,725,459 | Institution | 3.22% | 30,287,982 | |
| 3,498,005 | Institution | 3.03% | 28,438,781 | |
| 3,389,514 | Institution | 2.93% | 27,556,749 | |
| 2,745,943 | Institution | 2.38% | 22,324,517 | |
| 1,897,852 | Institution | 1.64% | 15,429,537 | |
| 1,766,984 | Institution | 1.53% | 14,365,580 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,054,419 | Institution | 3.51% | 32,962,426 | |
| 3,725,459 | Institution | 3.22% | 30,287,982 | |
| 3,389,514 | Institution | 2.93% | 27,556,749 | |
| 1,897,852 | Institution | 1.64% | 15,429,537 | |
| 1,766,984 | Institution | 1.53% | 14,365,580 | |
| 1,439,616 | Institution | 1.25% | 11,704,078 | |
| 1,102,287 | Institution | 0.95% | 8,961,593 | |
| 850,883 | Institution | 0.74% | 6,917,679 | |
| 844,488 | Institution | 0.73% | 6,865,687 | |
| 799,932 | Institution | 0.69% | 6,503,447 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,435,390 | Institution | 5.57% | 51,418,766 | |
| 3,005,949 | Institution | 2.60% | 29,788,955 | |
| 1,865,903 | Institution | 1.62% | 15,169,791 | |
| 1,502,917 | Institution | 1.30% | 14,893,907 | |
| 1,385,268 | Institution | 1.20% | 10,245,098 | |
| 732,047 | Institution | 0.63% | 5,951,542 | |
| 664,317 | Institution | 0.58% | 5,400,897 | |
| 504,990 | Institution | 0.44% | 4,105,569 | |
| 475,680 | Institution | 0.41% | 3,800,683 | |
| 443,042 | Institution | 0.38% | 3,539,906 |
FAQ
Who Owns Arcutis Biotherapeutics (ARQT)?
Currently, no data Available
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
Currently, no data Available
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
SPDR owns the most shares of Arcutis Biotherapeutics (ARQT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.